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TNF= synthesis which is associated with anabolic effects characterized by 
an increase in body fat, 2) These observations provide the first evidence of 
a clinically beneficial influence of modulation of TNF~ in aHF. 
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~ Reiea,ae o f  Adrenomedul l ln From the Human Fall i .g 
Ventricle 
Michthisa Jot~sakt, Richard J. Rodeheffer, Margaret M. Redfield, 
Kazuhlro Yamamoto, Chi-Ming Wei, John C. Bumeit Jr.. Cardiorenal 
Research, Mayo Clinic, Roohester' MN 
Since the isOlation of adrenomedullin (ADM) from human pheochmmocy- 
toma, accumulating evidence has eluddated that ADM is a novel vesore- 
laxing and natriuretic peptide that may play an important role in cardiorenai 
regulation. Recently, we have reported that plasma conce,~ation of ADM 
is increased in patients with severe congestive heart failure (CHF) and that 
increased irnmunahistochemical staining w~ts observed in the falling verdric- 
ular myoc, ardium. The present study was designed to examine the plasma 
concentration of ADM in association with parameters of cardiovascular hemo- 
dynamics in c l '~ l  stages of human CHF and to test the hypothesis that he 
failing human ventricle secretes ADM thus contributing to plasma concentra- 
tions. Plasma concentration of ADM was measured in 34 patients with CHF 
(20 men and 14 women; mean age. 64,6 years old) and 9 normal subjects 
(3 men and 6 women; 55,6 years ok;, using a specific redioimmunoassey 
for ADM. Plasma ADM concentration was significantly increased in patients 
with CHF ('34.6 :E 3.0 pg/mt, p < 0,01 vs. normal) as compared with normal 
subjects (14.4 d: 2.7 pg/ml). Plasma concenlretion of ADM was increased 
in mild (NYHA clas~ if) and moderate CHF (NYHA dase III) as well as in 
severe CHF (NYHA class IV). There was a weak negative correlation be- 
tween plasma concentration of ADM and left ventricular ejection fraction (r 
= 0.39, p < 0.05). In 13 patients with CHF in whom plasma samples were 
obtained from aorta and anterior interventricular vein (AIV) which receives 
blood exclusively from the left ventricle, them was a significant step-up in 
plasma concentration of ADM between aorta (47.7 :E 9.6 pg/mt) and AIV 
(57,4 =i: 10,2 pg/ml, p < 0.01 vs. aorta), This study demonstrates that plasma 
concentration of ADM is increased in patients with mild as well as moderate 
and severe CHF, and suggests that failing ventricles contribute to the release 
of ADM in patients with CHF. 
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Stabil ity o f  Exercise Tolerance Test in Spite of  
.......... Coronary  Artery Disease Progression in Stable 
Angina 
Dimitris Tousoulis, Tom Crake ~, Graham Davies, Attilio Mased 2 Cardiology 
Units, Hammersmith Hospital, London: ~ St Bartholomew's Hospital, 
London; ~ Universita Caltolice, Rome 
We examined the relationship between changes in the exercise tolerance 
test and coronary artery dtseass progression in 27 patients with angina who 
remained clinically stable. They underwent repeat coronary angidgraphy 
after a inlenml of 27.3 :E 2.6 months. Stenosie severity was measured on 
the first and second angiograms using a computerized system. Although 
symptoms were unchanged in all, stenosis progression was observed in 11 
patients (group t) and not in 16 patients (group 2). In all patients the results 
Table I
Group I Group 2 
Rrst Second First Second 
angiogmm ...angl0gram anglogram angtogram 
Exerclse dumtlon (rain) 11.9:E 2.2 10.3±2.4 11.8±2.6 11.2±3.0 
~T depression at peak  1.13-;-0.5 1.4±0.4 1.32±0.5 1.31:E0.5 
exercise (ram) 
HR at peak 139±15 136:~18 140±13 t38:E 12 
exerdse (~m) 
Exerclse duration te 9.26± 2.1 8.15±2.3 9.5±2.5 9.1 ~:22 
1 mm ST SO (rain) 
HR at I I~rn ST segmewl 131:E12 133~14 134±72 130~11 
depression (bpm) 
8P- HR product al 204±26 193 :i: ~9 210=t:28 201:E21 
1 mm ST SD (mmHg.l~0m!__ 
bpm = beats per minute. HR = heart rate. BP = bleed pressure. 
of trP~zdmill exercise testing (modified Bruce protocol) in the month preceding 
the !iret angiegram was compared to that in the month precedir~- I the second 
ang=ogram. Exercise te~.ts were terminated by progressive angina or fatigue 
or when 2 mm ST segment depression had developed. Heart rate (HR) and 
heart rate-systolic blood pressure (HR-BP product) were recorded al 1 mm 
ST segment depression (SD) and at peak exercise in patients with positive 
exercise lasts; in patients with negative exercise tests heart rate and rate- 
pressure prnduct were recorded al peak exercise. The results (ms_an :E SEM) 
are shown in Table 1: 
In conclusion in patients with chronic stable angina Coronary stermses may 
progress without a signfficanl reduction of exercise duration, heart rate and 
rate-pressure product at 1 mm ST depression and at peak exercise. 
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~ I s  ,Calcium a Sensit ive Marker  for  Coronary 
Atheroselerosis? An Intmvascular Ultrasound Study 
o f  1548 Native Arteries 
Gary S. Mintz, Augusto D. Pichard, Jeffrey J, Popma, Lowell F. Sailer, 
Kenneth M. Kent, Rainer Hoffman, Jennifer Gdffin, David Kautman, 
Susan Yeu~g, J. Hope Pacera, Chester Clark, Marlin B. Leon. Washington 
Hospital Center, Washington, DC 
The detection of coronary after- calcification (Ca) ~ninvaaively is used tO 
screen patients for coronary atherosclerosis, To validate this approach, we 
used intmvascular ultrasound (IVUS) and quentifative angingraphy (mea- 
surement of lesion d~w~,ter stenosis) to study target lesion and referenc~ 
(Ref) Segment Ca in 1548 native vessels. 
Angiographic _< 25% 26-50% 51-75% 76--100% p 
di',meter stenosis 
P,'US Ca (%) (59) (72) (78) (83) 0.0033 
L~ siorl ~rc of Ca '~ 60±78 t02±108 121:E 110 118±109 0.0002 
Ref amolCa Q 24..E 47 28±59 43±81 42±84 0.036 
However, when Ca was co , red  to the IVUS measured plaque burden 
(plaque area/total arterial area}, the prevalence of Ca did not reach 70% until 
the IVUS plaque burden exceeded 75%: 
[vus plaque burden < 50% 51-75% 76-es% S1-1QO% p 
1VUS Ca (%) (2~) (40) GO) (73) < 0.0001 
An= of Ca Q 24--60 50±81 95±98 105±99 <0.0001 
We ¢onc/ude: The presence and magnitude of Ca parallels the IVUS 
plaque burden more closely than the angiographic dian~ter stenasia. Ca is 
present in 70=/0 of arteries with an angiographic diameter stenesis > 25°/= or 
art IVUS plaque burden > 75%, but in only 40% with a plaque burden 50-  
75%. Therefore, coronmy artery Ca is useful for identifying hemodynamically 
significant disease, but is relatively insensitive for detecting "subc!iniCaT" 
coronary atheroselerosie (large plaque burden in the absence of lumin'.~l 
compromise). 
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~ ' ~  Coronary Artery Calcif ication Sc~ening to Rule Out 
Acute Myoca~iial  Infarct ion Prior to Hospital 
Admission 
Tamas Balogh, Julia Hoif, Stuart Rich, Christopher J, Wotlklal. Univendty of 
Illinois at Chic~o, Chicago, IL 
Background: it is common practice to hospitalize pts presenting to the Emer- 
gency Room (ER) with chest pain (CP) incteding those without fxev~us 
history of coronary artery disease (CAD) or objective findings of m.tKcardtal 
tschemis. Electron beam tomography (EBT) can etiictently ider~ coronary 
artery calcium (CAC), which has been shown to be exclusively associated 
with coronary ather0sclereSis. The absence of CAC may be useful in identi- 
fying pts presenting to the ER with non-cardiac CP. 
Methods: Patients admitted from the ER with CP and without history of 
CAD, cocaine abuse or diagnostic ECG changes (5 74% of CP ndmiesions) 
were scanned for CAC. CAC screening was done within 7 days of admission. 
Positive CAC was defined as CAC scores >_ 1. Patients were ~,~0nitorad for 
coronary events (MI, unstable angina, PTCA or CABG) during hOst0italization 
and 30 days following discharge. 
Resulis: 133 pts, ages 53,1 :E 12.1 yra, (63% female) were s'c~lied. No pts 
were lost to follOw up after hospital discharge. Seven of 86 (8.1%) positive 
CAC pts had coronary events (4 MI, 1 PTCA, 2 CABG) during the follow 
up period. No patient without CAC (n = 47) developed an e~nt during the 
follow-up period. CAC was associated with events (Fisher's exact test p = 
o.o51) 
Conclusion: Utilization of EBT to detect CAC has the potential to identify 
pts presenting to the ER with CP with very low risk for comnsry events. CAC 
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screening of CP pts presenting to the ER could result in marked financ:al 
savings by eliminating unnecassaP/hospitalization. 
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Two Year Cardiac Cost After Cardiac catheterization 
- ~ Profound Impact of Revascularization After First 
PTC,~ Compared With Initial Medical or Surg;cal 
Therapy 
Stephen G. Ellis, Kimhody Brown, Gan Howell, Cheryl Ke~ck. 31eveland 
Clinic Foundalfon, Clevetan~ Ohio 
As capitation becomes the main form of payment for medical care, a shift 
in focus from in-hospltsl to long term cost of care will occur. Our database 
was queried to find all patients (pts) undergoing oath at the Cleveland Clinic 
(CCF) during 1993-4 who reported by that they received all lcllow-up cardiac 
care at CCR 38 data elements were compared to cost as determined by 
the Transition System Inc method. In a preliminary study, 350 pts (age = 
66 ± 10 yr, 38=/0 unstable angina, 25% prior CABG; initial treatment CABG 
= 28%, peroutanecus (pore) = 36%; follow-up 25:1:7 runs) were studied. 
24 month event-free (CABG, infarction) survival was 80% and cost $30822 
± 22709 {in 1993 $). P re -~ent  independent correlates of cost wore # 
medical comorbidities (e.g. azotomla) (+$2144/ea), oath status (emergency 
> urgent > elective), # diseased vessels (+$35011ea), smoking (+$5324). 
After adjustment for these factors, mean cost ($ x 1000) by initial (+follow 
up) treatment and # of diseased vessels is shove: 
l Vessel El Mad, o Pare x 1, V Perc x ~2, i Multivessel 5o l I^ oP~+CA~a.,, ^ I] + CA.G. / i~* -o  
o 
Heap 6 me. 12 mo.18 mo24 me. Hosp 6 me. 12 mo.18 mo.24 me. 
*p = 0,07 vs, medicine *p = 0.002 vs. ~BG 
Conclusions: For single vessel disease, initial pare may be cost effective 
vs. mad rx. For multi-vessel disease pts likely to need >_ 2 perc probably 
should have initial CABG. 
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~ Feladipine and Matoprolol CR In the Treatment ER 
of Patients With Stable Angina Pectods (FEMINA) 
An He Liem, Peter H. Dunselman, for the Working Group on Cardiovascular 
Research The Netherlands. Breda, The Netherlands 
The aim of the present study was to compare the substitution of metoproldi 
100/200 mg CR (M) by felodipine 10 mg ER (F) and the addition of F to 
M with continuation of M (control), in patients with stable effort angina and 
a positive exercise test despite optimal treatment with M. Accordingly, 356 
patients (mean age 62.6; resting heart rate < 65 bpm) were randomized to 
substitution of Mwith F (n = lf8), addition of Fto M (n = 119), or continuation of 
M (n = 119), Baseline characleristi~ did not differ significantly. Analysis was 
performed with the intention to treat approach, between group comparison 
of changes. Results after 5 weeks treatment am shown as changes from 
baseline. 
time until: F M + F M (control) 
End of exercise (e) 7 (35) 11 (43) 11 (43) 
Chest pain (e) 17 (66) 24 (62) (51) 
1 mm ST depression (s) 31 (72) 52 (59)* 13 (71) 
RPP at highest comparable 5511 (4030) *'~ -t031 (3068) -121 (3212) 
exert, level (mmHg/mfn) 
Adverse Events (no of patients) 50"* 28 19 
Mean (SD); *P < 0.05 vs M and F; ='P < 0.05 ve M + F and M 
Conclusion: addition of F to M results in beneficial effects on myoCardial 
ischemia during exercise, such as delaying time until onset of ST depression. 
Substitution of M with F results in comparable xercise results, at the expense 
of more adverse events and an Increase in rate pressure product (RPP) 
compared to M. In patients with symptomatic angina despite optimal /~- 
blockade, addition of F is to be preferred to substitution with F. 
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~ Efficacy end Safety of High 11boracic Epidural 
Analgesia Producing Sympathatl¢ Blockade to Treat 
Medically and Surgically Refractory Angina Pectoris 
Patdcla Gramllng-Babb, Michael J. Miller, ~¢ott 1". Reeves, A. 
Jackson Cmmbley, John R. Handy, Sunll J. Petal, Brian G. Cuddy, 
Raymond C. Roy, Michael R. Zile. Medical UnivereltyofSC, VA Medical 
Center, Charleston, SC 
Surgical ~ympethectomy Can relieve symptoms of angina in patients with 
refractory angina, However, in these high flsk patients this extensive surgery 
results in a high morbidity and mertafity. This same sympathetic I~ockade 
can now be produced using high.th0raclc epidurat analgesia (HTEA). Dudng 
the past 12 months, we treated 10 consecutive patients with NYHA Class IV 
angina despite three drug therapy (nitrates, beta-bleckede, calcium channel 
blockade) with HTEA. In 8 men and 2 women, age 58 =1:5 years, with 
extensive 3 vessel corena|y disease and ejection fraction 40 ± 5%, HTEA 
(T~-T4) was placed either pamutaneously or surgically with radiographic 
confirmation (by fluoroscopy or CT scan) of placement. Buplvaoaine (amide 
local anesthetic, 0.25-0.5%) was given as a bolus and then maintained either 
as a continuous infusion or an intermittent rebelus. A catheter was placed 
for 7 days in 4 patients, 14 clays in 3 patients and 90 days in 3 patients. 
Results: Prior to HTEA, each patient was deemed unsuitable for corenan] 
bypass surgery or percufaneous camnery angieplasty and had NYHA Clnss 
IV symptoms of angina, Six of 10 patients required intravenous nitroglycerin 
and h~n and were unable to be discharged from the intensive care unit. 
Two patients l~lulred an intra-ecrtic balloon pump. Following HTEA, all 10 
patients had improved symptoms with 5 patients improving to NYHA Class 
II symptoms and 5 to Class IlL All 5 patients on IV nttroglycedn, hep~n 
or int~a-aortic balloon pump had these mndalifies discontinued. Nine of 10 
patients were subsequently discharged from the hospital. One patient died 
of a noncardiao cause. Them wee no catheter elated deaths. There were 
2 catheter related complications necessitating catheter emoval. O~e patient 
developed a local infection and one had catheter occlusion secondary to 
fibrosis. No patient suffered a myocardial infarction or a significant arrbythmia. 
Condusion: In patients with otherwise intractable angina pectods, HTEA is a 
safe, effective mndality which produces ymptomatic relief of angina pactods 
and an increased activity level. 
Surgery  fo r  Va lves  and  Aneurysms 
Monday, March 25, 1996, 4:00 p .m. -5 :30 p.m. 
Orange County Convent ion Center, Room 315 
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Should Patients W'dh Symptomatic Coronary Artery 
Disease Plus Aortic Valve Disease of Borderline 
Clinical Significance Have Aortic Valve Replacement 
at the Time of Initial CABG? 
James Hochmin, John C. Lucks, J. Kevin Harrison, Thomas M. Bashom, 
Walter G. Weft, Robert H. Jones, James E. I.owe, William D. White, Donald 
D. Glower. Duke University, Durham, NC 
Few data exist to help the clinician decide whether to proceed with aortic 
valve replacement (AVR) at the time of CABG In patients with symptomatic 
coronary artery disease (CAD) and aottlc valve (AV) disease of borderline 
clinical significance. In order to understand the outcomes of AVR combined 
with CABG vs. CABG alone, we compared 62 patients (Group t) with aortto 
insufficiency (2 + orgreater) and/or aortic stenasis (mean aortic valve gradient 
of 10 mm Hg or greater) felt not to be significant enough to warrant AVR with 
414 patients (Group 2) who had the combined procedure. 
No significant differences in all-cause or cardiac mortality existed between 
the treatment groups. However, patients In Group 1 required renporetion 
for AVR significantly more often then Group 2 patients. The results were 
unchanged after controlling for EF, age, heart failure class, year of surgery 
and type of AV disease. 
6 Year Follow.up" Group I Group 2 
CABG Only AVR + CAEG 
All Cause Mortal~ 39.7% 39.1% p = 0.81 
Cardiac Mortality 34.3% 22,9% p :  0.35 
AV Reoperation 24.3% 3.0% p = 0.0003 
"Kaplan-Meier Estimates 
These results demonstrate that, In patients with symptomatic GAD and 
borderline clinically significant AV disease, replacing the AV at the time of 
initial CABG will significantly reduce the need for aortic valve reoporation 
without increasing mortality. 
